{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "10"
        },
        "variant_string_id": "DJ-1 L10P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the gene encoding DJ-1 protein are causal of autosomal recessive early-onset parkinsonism.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for the L10P variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study assessed protein stability, dimerization, solubility, subcellular localization, and protective function in comparison to WT and the L166P DJ-1 pathogenic variant.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used effectively models or reflects the disease pathogenesis/mechanism defined in Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Experiments were conducted in triplicates with normal DMEM/FBS with or without 20 µM MG-132 for 0, 1, 3, 6, and 10 hours.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates were used, meeting the criteria for proceeding to Sub-step 3c.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "WT and L166P DJ-1 were used as controls.",
          "judgment": "Yes",
          "reasoning": "Known pathogenic variants were used as controls, meeting the criteria for proceeding to Step 4.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Statistical analyses were performed using GraphPad Prism 5.0.",
          "judgment": "No",
          "reasoning": "The paper does not provide sufficient statistical analyses to estimate or calculate OddsPath for the functional data.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study used WT and L166P DJ-1 as controls.",
          "judgment": "No",
          "reasoning": "Less than 11 total benign/pathogenic variant controls were used across the entire study.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The L10P variant in DJ-1 was assessed for its pathogenic potential through various functional assays. The evidence supports a pathogenic role, albeit at a supporting strength, due to the use of known pathogenic controls and the demonstration of reduced protein stability and altered dimerization."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "P",
          "alt": "DEL",
          "position": "158"
        },
        "variant_string_id": "DJ-1 P158DEL"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the gene encoding DJ-1 protein are causal of autosomal recessive early-onset parkinsonism.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for the P158DEL variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study assessed protein stability, dimerization, solubility, subcellular localization, and protective function in comparison to WT and the L166P DJ-1 pathogenic variant.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used effectively models or reflects the disease pathogenesis/mechanism defined in Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Experiments were conducted in triplicates with normal DMEM/FBS with or without 20 µM MG-132 for 0, 1, 3, 6, and 10 hours.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates were used, meeting the criteria for proceeding to Sub-step 3c.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "WT and L166P DJ-1 were used as controls.",
          "judgment": "Yes",
          "reasoning": "Known pathogenic variants were used as controls, meeting the criteria for proceeding to Step 4.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Statistical analyses were performed using GraphPad Prism 5.0.",
          "judgment": "No",
          "reasoning": "The paper does not provide sufficient statistical analyses to estimate or calculate OddsPath for the functional data.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study used WT and L166P DJ-1 as controls.",
          "judgment": "No",
          "reasoning": "Less than 11 total benign/pathogenic variant controls were used across the entire study.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The P158DEL variant in DJ-1 was assessed for its pathogenic potential through various functional assays. The evidence supports a pathogenic role, albeit at a supporting strength, due to the use of known pathogenic controls and the demonstration of reduced protein stability and altered dimerization."
    }
  ]
}